Airway and lung tissue mechanics in asthma : Effects of albuterol
We examined the partitioning of total lung resistance (RL) into airway resistance (Raw) and tissue resistance (Rti) in patients with mild to moderate asthma (baseline FEV1, 54 to 91% of predicted) before and after albuterol inhalation. An optimal ventilator waveform was used to measure RL and lung e...
Gespeichert in:
Veröffentlicht in: | American journal of respiratory and critical care medicine 1999, Vol.159 (1), p.169-178 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 178 |
---|---|
container_issue | 1 |
container_start_page | 169 |
container_title | American journal of respiratory and critical care medicine |
container_volume | 159 |
creator | KACZKA, D. W INGENITO, E. P ISRAEL, E LUTCHEN, K. R |
description | We examined the partitioning of total lung resistance (RL) into airway resistance (Raw) and tissue resistance (Rti) in patients with mild to moderate asthma (baseline FEV1, 54 to 91% of predicted) before and after albuterol inhalation. An optimal ventilator waveform was used to measure RL and lung elastance (EL) in 21 asthmatics from approximately 0.1 to 8 Hz during tidal excursions. Analysis of the RL and EL provided separate estimates of airway and lung tissue properties. Eleven subjects, classified as Type A asthmatics, displayed slightly elevated RL but normal EL. Their data were well described with a model consisting of homogeneous airways leading to viscoelastic tissues before and after albuterol. The other 10 subjects, classified as Type B asthmatics, demonstrated highly elevated RL and an EL that became highly elevated at frequencies above 2 Hz. These subjects required the inclusion of an airway wall compliance in the model prealbuterol but not postalbuterol. This suggests that the Type B subjects were experiencing pronounced constriction in the periphery of the lung, resulting in shunting of flow into the airway walls. Spirometric data were consistent with higher constriction in Type B subjects. Both groups demonstrated significant (p < 0.05) decreases in Raw and tissue damping after albuterol, but tissue elastance decreased only in the Type B group. The percent contributions of Raw and Rti to RL were similar in both groups and did not change after albuterol. We conclude that in asthma, Raw comprises the majority (> 70%) of RL at breathing frequencies. The relative contributions of Raw and Rti to RL appear to be independent of the degree of smooth muscle constriction. |
doi_str_mv | 10.1164/ajrccm.159.1.9709109 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69554121</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69554121</sourcerecordid><originalsourceid>FETCH-LOGICAL-c280t-7320ab4944efcc69fdb9ad04687ef6a1c9deee35cc57fcf2b454d0d8b7a9a6413</originalsourceid><addsrcrecordid>eNpFkMtKxDAUhoMoo46-gUIW4q41aZOmcTcM4wUG3Ci4C6enidOhlzFpkXl7O0zR1fkP_2XxEXLDWcx5Jh5g6xGbmEsd81grpjnTJ-SCy1RGYvxPR81UGgmhP8_JZQhbxniSczYjM52rJE-zC7JYVP4H9hTaktZD-0X7KoTB0sbiBtoKA61aCqHfNEAf6co5i32gnaNQF0NvfVdfkTMHdbDX052Tj6fV-_IlWr89vy4X6wiTnPWRShMGhdBCWIeYaVcWGkomslxZlwFHXVprU4kolUOXFEKKkpV5oUBDJng6J_fH3Z3vvgcbetNUAW1dQ2u7IZhMSyl4cgiKYxB9F4K3zux81YDfG87MgZw5kjMjOcPNRG6s3U77Q9HY8q80oRr9u8mHgFA7Dy1W4X87EzpRLP0Fvnh4YA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69554121</pqid></control><display><type>article</type><title>Airway and lung tissue mechanics in asthma : Effects of albuterol</title><source>MEDLINE</source><source>American Thoracic Society (ATS) Journals Online</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>KACZKA, D. W ; INGENITO, E. P ; ISRAEL, E ; LUTCHEN, K. R</creator><creatorcontrib>KACZKA, D. W ; INGENITO, E. P ; ISRAEL, E ; LUTCHEN, K. R</creatorcontrib><description>We examined the partitioning of total lung resistance (RL) into airway resistance (Raw) and tissue resistance (Rti) in patients with mild to moderate asthma (baseline FEV1, 54 to 91% of predicted) before and after albuterol inhalation. An optimal ventilator waveform was used to measure RL and lung elastance (EL) in 21 asthmatics from approximately 0.1 to 8 Hz during tidal excursions. Analysis of the RL and EL provided separate estimates of airway and lung tissue properties. Eleven subjects, classified as Type A asthmatics, displayed slightly elevated RL but normal EL. Their data were well described with a model consisting of homogeneous airways leading to viscoelastic tissues before and after albuterol. The other 10 subjects, classified as Type B asthmatics, demonstrated highly elevated RL and an EL that became highly elevated at frequencies above 2 Hz. These subjects required the inclusion of an airway wall compliance in the model prealbuterol but not postalbuterol. This suggests that the Type B subjects were experiencing pronounced constriction in the periphery of the lung, resulting in shunting of flow into the airway walls. Spirometric data were consistent with higher constriction in Type B subjects. Both groups demonstrated significant (p < 0.05) decreases in Raw and tissue damping after albuterol, but tissue elastance decreased only in the Type B group. The percent contributions of Raw and Rti to RL were similar in both groups and did not change after albuterol. We conclude that in asthma, Raw comprises the majority (> 70%) of RL at breathing frequencies. The relative contributions of Raw and Rti to RL appear to be independent of the degree of smooth muscle constriction.</description><identifier>ISSN: 1073-449X</identifier><identifier>EISSN: 1535-4970</identifier><identifier>DOI: 10.1164/ajrccm.159.1.9709109</identifier><identifier>PMID: 9872836</identifier><language>eng</language><publisher>New York, NY: American Lung Association</publisher><subject>Administration, Inhalation ; Adolescent ; Adult ; Airway Resistance - drug effects ; Airway Resistance - physiology ; Albuterol - administration & dosage ; Albuterol - therapeutic use ; Asthma - drug therapy ; Asthma - physiopathology ; Biological and medical sciences ; Bronchodilator Agents - administration & dosage ; Bronchodilator Agents - therapeutic use ; Chronic obstructive pulmonary disease, asthma ; Female ; Forced Expiratory Volume - physiology ; Humans ; Lung Compliance - drug effects ; Lung Compliance - physiology ; Male ; Medical sciences ; Middle Aged ; Pneumology ; Respiratory Mechanics - drug effects ; Spirometry</subject><ispartof>American journal of respiratory and critical care medicine, 1999, Vol.159 (1), p.169-178</ispartof><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c280t-7320ab4944efcc69fdb9ad04687ef6a1c9deee35cc57fcf2b454d0d8b7a9a6413</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,4011,27900,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1649270$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9872836$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KACZKA, D. W</creatorcontrib><creatorcontrib>INGENITO, E. P</creatorcontrib><creatorcontrib>ISRAEL, E</creatorcontrib><creatorcontrib>LUTCHEN, K. R</creatorcontrib><title>Airway and lung tissue mechanics in asthma : Effects of albuterol</title><title>American journal of respiratory and critical care medicine</title><addtitle>Am J Respir Crit Care Med</addtitle><description>We examined the partitioning of total lung resistance (RL) into airway resistance (Raw) and tissue resistance (Rti) in patients with mild to moderate asthma (baseline FEV1, 54 to 91% of predicted) before and after albuterol inhalation. An optimal ventilator waveform was used to measure RL and lung elastance (EL) in 21 asthmatics from approximately 0.1 to 8 Hz during tidal excursions. Analysis of the RL and EL provided separate estimates of airway and lung tissue properties. Eleven subjects, classified as Type A asthmatics, displayed slightly elevated RL but normal EL. Their data were well described with a model consisting of homogeneous airways leading to viscoelastic tissues before and after albuterol. The other 10 subjects, classified as Type B asthmatics, demonstrated highly elevated RL and an EL that became highly elevated at frequencies above 2 Hz. These subjects required the inclusion of an airway wall compliance in the model prealbuterol but not postalbuterol. This suggests that the Type B subjects were experiencing pronounced constriction in the periphery of the lung, resulting in shunting of flow into the airway walls. Spirometric data were consistent with higher constriction in Type B subjects. Both groups demonstrated significant (p < 0.05) decreases in Raw and tissue damping after albuterol, but tissue elastance decreased only in the Type B group. The percent contributions of Raw and Rti to RL were similar in both groups and did not change after albuterol. We conclude that in asthma, Raw comprises the majority (> 70%) of RL at breathing frequencies. The relative contributions of Raw and Rti to RL appear to be independent of the degree of smooth muscle constriction.</description><subject>Administration, Inhalation</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Airway Resistance - drug effects</subject><subject>Airway Resistance - physiology</subject><subject>Albuterol - administration & dosage</subject><subject>Albuterol - therapeutic use</subject><subject>Asthma - drug therapy</subject><subject>Asthma - physiopathology</subject><subject>Biological and medical sciences</subject><subject>Bronchodilator Agents - administration & dosage</subject><subject>Bronchodilator Agents - therapeutic use</subject><subject>Chronic obstructive pulmonary disease, asthma</subject><subject>Female</subject><subject>Forced Expiratory Volume - physiology</subject><subject>Humans</subject><subject>Lung Compliance - drug effects</subject><subject>Lung Compliance - physiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pneumology</subject><subject>Respiratory Mechanics - drug effects</subject><subject>Spirometry</subject><issn>1073-449X</issn><issn>1535-4970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkMtKxDAUhoMoo46-gUIW4q41aZOmcTcM4wUG3Ci4C6enidOhlzFpkXl7O0zR1fkP_2XxEXLDWcx5Jh5g6xGbmEsd81grpjnTJ-SCy1RGYvxPR81UGgmhP8_JZQhbxniSczYjM52rJE-zC7JYVP4H9hTaktZD-0X7KoTB0sbiBtoKA61aCqHfNEAf6co5i32gnaNQF0NvfVdfkTMHdbDX052Tj6fV-_IlWr89vy4X6wiTnPWRShMGhdBCWIeYaVcWGkomslxZlwFHXVprU4kolUOXFEKKkpV5oUBDJng6J_fH3Z3vvgcbetNUAW1dQ2u7IZhMSyl4cgiKYxB9F4K3zux81YDfG87MgZw5kjMjOcPNRG6s3U77Q9HY8q80oRr9u8mHgFA7Dy1W4X87EzpRLP0Fvnh4YA</recordid><startdate>1999</startdate><enddate>1999</enddate><creator>KACZKA, D. W</creator><creator>INGENITO, E. P</creator><creator>ISRAEL, E</creator><creator>LUTCHEN, K. R</creator><general>American Lung Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1999</creationdate><title>Airway and lung tissue mechanics in asthma : Effects of albuterol</title><author>KACZKA, D. W ; INGENITO, E. P ; ISRAEL, E ; LUTCHEN, K. R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c280t-7320ab4944efcc69fdb9ad04687ef6a1c9deee35cc57fcf2b454d0d8b7a9a6413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Administration, Inhalation</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Airway Resistance - drug effects</topic><topic>Airway Resistance - physiology</topic><topic>Albuterol - administration & dosage</topic><topic>Albuterol - therapeutic use</topic><topic>Asthma - drug therapy</topic><topic>Asthma - physiopathology</topic><topic>Biological and medical sciences</topic><topic>Bronchodilator Agents - administration & dosage</topic><topic>Bronchodilator Agents - therapeutic use</topic><topic>Chronic obstructive pulmonary disease, asthma</topic><topic>Female</topic><topic>Forced Expiratory Volume - physiology</topic><topic>Humans</topic><topic>Lung Compliance - drug effects</topic><topic>Lung Compliance - physiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pneumology</topic><topic>Respiratory Mechanics - drug effects</topic><topic>Spirometry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KACZKA, D. W</creatorcontrib><creatorcontrib>INGENITO, E. P</creatorcontrib><creatorcontrib>ISRAEL, E</creatorcontrib><creatorcontrib>LUTCHEN, K. R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of respiratory and critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KACZKA, D. W</au><au>INGENITO, E. P</au><au>ISRAEL, E</au><au>LUTCHEN, K. R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Airway and lung tissue mechanics in asthma : Effects of albuterol</atitle><jtitle>American journal of respiratory and critical care medicine</jtitle><addtitle>Am J Respir Crit Care Med</addtitle><date>1999</date><risdate>1999</risdate><volume>159</volume><issue>1</issue><spage>169</spage><epage>178</epage><pages>169-178</pages><issn>1073-449X</issn><eissn>1535-4970</eissn><abstract>We examined the partitioning of total lung resistance (RL) into airway resistance (Raw) and tissue resistance (Rti) in patients with mild to moderate asthma (baseline FEV1, 54 to 91% of predicted) before and after albuterol inhalation. An optimal ventilator waveform was used to measure RL and lung elastance (EL) in 21 asthmatics from approximately 0.1 to 8 Hz during tidal excursions. Analysis of the RL and EL provided separate estimates of airway and lung tissue properties. Eleven subjects, classified as Type A asthmatics, displayed slightly elevated RL but normal EL. Their data were well described with a model consisting of homogeneous airways leading to viscoelastic tissues before and after albuterol. The other 10 subjects, classified as Type B asthmatics, demonstrated highly elevated RL and an EL that became highly elevated at frequencies above 2 Hz. These subjects required the inclusion of an airway wall compliance in the model prealbuterol but not postalbuterol. This suggests that the Type B subjects were experiencing pronounced constriction in the periphery of the lung, resulting in shunting of flow into the airway walls. Spirometric data were consistent with higher constriction in Type B subjects. Both groups demonstrated significant (p < 0.05) decreases in Raw and tissue damping after albuterol, but tissue elastance decreased only in the Type B group. The percent contributions of Raw and Rti to RL were similar in both groups and did not change after albuterol. We conclude that in asthma, Raw comprises the majority (> 70%) of RL at breathing frequencies. The relative contributions of Raw and Rti to RL appear to be independent of the degree of smooth muscle constriction.</abstract><cop>New York, NY</cop><pub>American Lung Association</pub><pmid>9872836</pmid><doi>10.1164/ajrccm.159.1.9709109</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1073-449X |
ispartof | American journal of respiratory and critical care medicine, 1999, Vol.159 (1), p.169-178 |
issn | 1073-449X 1535-4970 |
language | eng |
recordid | cdi_proquest_miscellaneous_69554121 |
source | MEDLINE; American Thoracic Society (ATS) Journals Online; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete |
subjects | Administration, Inhalation Adolescent Adult Airway Resistance - drug effects Airway Resistance - physiology Albuterol - administration & dosage Albuterol - therapeutic use Asthma - drug therapy Asthma - physiopathology Biological and medical sciences Bronchodilator Agents - administration & dosage Bronchodilator Agents - therapeutic use Chronic obstructive pulmonary disease, asthma Female Forced Expiratory Volume - physiology Humans Lung Compliance - drug effects Lung Compliance - physiology Male Medical sciences Middle Aged Pneumology Respiratory Mechanics - drug effects Spirometry |
title | Airway and lung tissue mechanics in asthma : Effects of albuterol |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T07%3A09%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Airway%20and%20lung%20tissue%20mechanics%20in%20asthma%20:%20Effects%20of%20albuterol&rft.jtitle=American%20journal%20of%20respiratory%20and%20critical%20care%20medicine&rft.au=KACZKA,%20D.%20W&rft.date=1999&rft.volume=159&rft.issue=1&rft.spage=169&rft.epage=178&rft.pages=169-178&rft.issn=1073-449X&rft.eissn=1535-4970&rft_id=info:doi/10.1164/ajrccm.159.1.9709109&rft_dat=%3Cproquest_cross%3E69554121%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69554121&rft_id=info:pmid/9872836&rfr_iscdi=true |